Risk factors for early catheter-related infections in cancer patients

Cancer

Volumn 110, Issue 7, 2007, Pages 1586-1592

  Penel, Nicolas ^a,b,e   Neu, Jean Charles ^a   Clisant, Stéphanie ^c   Hoppe, Helga ^a   Devos, Patrick ^b   Yazdanpanah, Yazdan ^b,d  

^a Oscar Lambret Comprehensive Cancer Center   (France)

^b UNIV LILLE   (France)

^c Oscar Lambret Cancer Center   (France)

^d University Service for Infectious Pathologies and Travelers   (France)

^e CENTRE OSCAR LAMBRET   (France)

Author keywords

Cancer; Catheter; Nosocomial infection; Quality; Supportive care

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PATIENT; CATHETER INFECTION; CENTRAL VENOUS CATHETER; COHORT ANALYSIS; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HOSPITAL INFECTION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PARENTERAL NUTRITION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY CONTROL; RISK FACTOR; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFECTION; MALE; MIDDLE AGED; NEOPLASMS; ODDS RATIO; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 34648813412     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22942     Document Type: Article

References (30)

1. Labourey J-L, Lacroix P, Genet D, et al. Thrombotic complications of implanted central venous access devices: a prospective evaluation. Bull Cancer. 2004;91:431-436.
2. Pottecher B, Herbrecht R, Blanc-Vincent MR et al. Standards, options, recommendations (SOR) for the surveillance and prevention of nosocomial infections in oncology [in French]. Bull Cancer. 2000;87:557-591.
3. Institut de Veille Sanitaire. Inquiry of national prevalence, 2001. Results [in French]. Available at URL: http://www.invs.sante.fr. Accessed August 1, 2007.
4. Fratino G, Molinari AC, Parodi S, et al. Central venous catheter-related complications in children with oncological/haematological diseases: an observational study of 418 devices. Ann Oncol. 2005;16:648-654
5. Verso M, Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol. 2003;21:3665-3675
6. van de Wetering MD, van Woensel JBM. Prophylactic antibiotics for preventing early central venous catheter Gram positive infections in oncology patients (review). Available at: www.thecochranelibrary.com Cochrane Database Syst Rev. 2007;(1):CD003295.
7. Groeger JS, Lucas AB, Croit D, et al. A prospective, randomized evaluation of the effect of silver impregnated subcutaneous cuffs for preventing tunneled chronic venous access catheter infection in cancer patients. Ann Surg. 1993;218:206-210.
8. Mueller BU, Skelton J, Callender DP, et al. A prospective randomized trial comparing the infectious and non-infectious complications of an externalized catheter versus a subcutaneously implanted device in cancer. J Clin Oncol. 1992;10:1943-1948.
9. Hanna H, Benjamin R, Chatzinikolaou I, et al. Long-term silicone-central venous catheters impregnated with minocycline and rifampicin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial. J Clin Oncol. 2004;22:3163-3171.
10. Richards M, Edwards J, Culver D, et al. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol. 2000;21:510-515.
11. Jarvis W. Selected aspects of the socio-economic impact of nosocomial infections: morbidity, mortality, cost and prevention. Infect Control Hosp Epidemiol. 1996;17:552-557.
12. Pittet D, Tarara D, Wenzel R. Nosocomial bloodstream infection in critically ill patients: excess of length of stay, extra costs, and attributable mortality. JAMA. 1994;271:1598-1601.
13. Haley R, Scharberg D, Crossley K, et al. Extra charges and prolongation of stay attributable to nosocomial infections: a prospective interhospital comparison. Am J Med. 1981;70: 51-58.
14. Howell PB, Walters PE, Donowitz GR, Farr BM. Risk factors for adult patients with cancer who have tunneled central venous catheters. Cancer. 1995;75:1367-1375.
15. Seigman-Igra Y, Anglim AM, Shapiro DE, Adal KA, Strain BA, Farr BM. Diagnosis of vascular catheter-related bloodstream infection: a meta-analysis. J Clin Microbiol. 1997;35:928-936.
16. Maki DG, Weise CE, Sarafin HW. A semi-quantitative culture for identifying intravascular catheter infection. N Engl J Med. 1977;296:1305-1309.
17. Poorter RL, Lauw FN, Bemelman WA, Bakker PJ, Taat CW, Veenhof CH. Complications of an implantable venous access device (Port-a-Cath) during intermittent continuous infusion of chemotherapy. Eur J Cancer. 1996;32:2262-2266.
18. Clarke DE, Raffin TA. Infections complications of indwelling long-term central venous catheter. Chest. 1990;97:966-972.
19. Press OW, Ramsey PG, Larson EN, Fefer A, Hickman RO. Hickman catheter infections in patients with malignancies. Medicine (Baltimore). 1984;63:189-200.
20. Pegues D, Axerold P, McClarren C, et al. Comparison of infections in Hickman and implanted port catheters in adult solid tumor patients. J Surg Oncol. 1992;49:156-162.
21. Keung YK, Watkins K, Chen SC, Groshen S, Silberman H, Douer D. Comparative study of infectious complications of different types of central access devices. Cancer. 1994;73:2832-2837.
22. Darouiche O, Raad II, Heard SO, et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med. 1999;340:1-8.
23. Mermel L, Farr B, Sherertz R, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis. 2001;32:1249-2172.
24. Morris JA, Gardner MJ. Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates. BMJ. 1988;296:1313-1316.
25. Heinze G, Schemper M. A solution to the problem of separation in logistic regression. Stat Med. 2002;21:2409-2419.
26. Lemeshow S, Hosmer DW. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol. 1982;115:92-106.
27. National Agency for the Accreditation and Evaluation of Health (ANAES). The evaluation of professional practices for the establishment of health: evaluation of the quality of utilization and monitoring of implantable port catheters [in French]. Paris, France: National Agency for the Accreditation and Evaluation of Health; 2000. Available at URL: http://www.anaes.fr. Accessed August 1, 2007.
28. Raad I, Bodey GP. Infectious complications of indwelling vascular catheters. Clin Infect Dis. 1999;15:197-210.
29. Mirro J Jr, Rao BN, Stokes DC, et al. A prospective study of Hickman/Broviac catheters and implantable ports in pediatric oncology patients. J Clin Oncol. 1989;7:212-222.
30. Richet H, Hubert B, Nitenberg G, et al. Prospective multicenter study of vascular-catheter-related complications and risk factor for positive central-catheter cultures in intensive care unit patients. J Clin Microbiol. 1990;28:2520-2525.